BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, March 15, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 23, 2011
View Archived Issues
Dutasteride reduces risk of prostate cancer in men with small prostates
Read More
Denosumab delays pain interference in patients with CRPC
Read More
RespiVent reports new PI3K-delta inhibitors
Read More
Canadian researchers present new polypeptide PTEN inhibitors
Read More
FDA advisory committee recommends retention of indication for Abbott's Trilipix
Read More
S-APP-alpha is a possible biomarker in fragile X syndrome and autism
Read More
Gamma-sarcoglycan gene therapy safe in patients with limb girdle muscular dystrophy type 2C
Read More
ZIOPHARM Oncology files IND application for phase I Ad-RTS-IL-12 trial in melanoma
Read More
GSK prepares novel agents for HCV infection
Read More
Spanish researchers disclose new acetylcholinesterase inhibitors
Read More
New modulators of metabotropic glutamate mGlu4 receptor claimed
Read More
New selective adenosine A2A receptor antagonists patented
Read More
FDA clears Repligen's phase I trial of RG-3039 for spinal muscular atrophy
Read More
Medivir reports 48-week interim results from ASPIRE phase IIb trial of TMC-435
Read More
CHMP recommends conditional marketing authorization of Fampyra
Read More
Study of Actelion's prostanoid DP2 receptor antagonist in allergic rhinitis meets primary endpoint
Read More
GSK and Human Genome Sciences receive CHMP positive opinion for Benlysta
Read More
European Commission approves Eliquis for prevention of VTE after hip or knee replacement
Read More
CHMP recommends approval of Vibativ for nosocomial pneumonia caused by MRSA
Read More
Pfizer receives FDA approval for Sutent in advanced pancreatic neuroendocrine tumors
Read More
Auxilium Pharmaceuticals receives payment after launching Xiapex in Germany
Read More
Phase II data disclosed on fulranumab in low back and osteoarthritic pain
Read More
EMA committee recommends accelerated approval of Victrelis for hepatitis C genotype 1
Read More
PharmaGap's anticancer candidate GAP-107B8 shows improved potency and bioavailability in liposomes
Read More
Viralytics receives FDA reply regarding clinical hold on phase II Cavatek trial in melanoma
Read More
